Journal for ImmunoTherapy of Cancer (Nov 2021)
30 Blood-based glycoprotein signatures in advanced non-small-cell lung carcinoma (NSCLC) receiving first-line immune checkpoint blockade
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)